Search results
AbbVie Inc. (NYSE:ABBV) is favoured by institutional owners who hold 71% of the company
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
AbbVie Inc.'s (NYSE:ABBV) Intrinsic Value Is Potentially 81% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Using the 2 Stage Free Cash Flow to Equity, AbbVie fair value estimate is US$275 AbbVie...
AbbVie (NYSE:ABBV) shareholders have earned a 18% CAGR over the last three years
Simply Wall St. via Yahoo Finance· 11 months agoWhile AbbVie Inc. (NYSE:ABBV) shareholders are probably generally happy, the stock hasn't had...
Insiders At AbbVie Sold US$8.4m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Finance· 10 months agoThe fact that multiple AbbVie Inc. (NYSE:ABBV) insiders offloaded a considerable amount of shares...
With 71% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
AbbVie Inc.'s (NYSE:ABBV) Share Price Could Signal Some Risk
Simply Wall St. via Yahoo Finance· 2 years agoWith a price-to-earnings (or "P/E") ratio of 19.5x AbbVie Inc. (NYSE:ABBV) may be sending bearish...
AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three...
Simply Wall St. via Yahoo Finance· 1 year agoAbbVie Inc. (NYSE:ABBV) shareholders have seen the share price descend 13% over the month. But don't...
AbbVie (ABBV) to Acquire Cerevel Therapeutics (CERE) for $8.7B
Zacks via Yahoo Finance· 5 months agoAbbVie ABBV has announced a definitive agreement to acquire neuroscience drugmaker, Cerevel...
AbbVie Inc. (NYSE:ABBV) Passed Our Checks, And It's About To Pay A US$1.48 Dividend
Simply Wall St. via Yahoo Finance· 1 year agoIt looks like AbbVie Inc. (NYSE:ABBV) is about to go ex-dividend in the next four days. The...